Novo Nordisk’s Ozempic receives EMA’s nod for chronic kidney disease treatment
HQ Team December 13, 2024: Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)
HQ Team December 13, 2024: The Institute for Clinical and Economic Review (ICER) has released a new report revealing that five high-expenditure drugs
Bharti Jayshankar December 13, 2024: AstraZeneca and Merck have announced long-term results from the OlympiA Phase 3 trial, showing that Lynparza (olaparib) significantly
HQ Team December 12, 2024: Filamon Limited, an Australian biotech company, has announced a significant advancement in dementia treatment with its new drug,
About one person every second or 42 million people each year are estimated to contract genital herpes infection worldwide, according to the World
HQ Team December 11, 2024: The U.S. Food and Drug Administration (FDA) has announced a halt to all clinical trials for respiratory syncytial
Vinit Shetty December 9, 2024: We bring you here the blogs of Mr Vinit Shetty, encapsulating his remarkable journey with sensorimotor neuropathy. Though
Eli Lilly and Company will invest $3 billion in the US to expand its manufacturing facility to meet a rise in demand for